CarelonRx is the pharmacy benefit manager owned by Elevance Health, formerly Anthem, Inc, and its claims audits carry the same recoupment and network exposure pharmacies already face from OptumRx, CVS Caremark and other PBMs. A CarelonRx audit reviews a pharmacy's dispensing and billing records against the plan-specific network agreement and CarelonRx's own provider manual, and documentation gaps can escalate quickly: from a claims-level recoupment demand to a referral to the health plan's Special Investigations Unit (SIU). Independent and specialty pharmacies dispensing under Anthem-affiliated Medicaid, Medicare Advantage or commercial plans should treat a CarelonRx audit notice as a legal matter from the day it arrives, not paperwork routed to billing staff.
CarelonRx's Role in the Pharmacy Claims Chain
CarelonRx began operating as IngenioRx, Anthem's in-house pharmacy benefit manager, and took the CarelonRx name on January 1, 2023, once Anthem completed its rebrand to Elevance Health and consolidated its healthcare services businesses under the Carelon brand. CarelonRx now administers pharmacy benefits for Anthem-branded Medicaid, Medicare Advantage and commercial plans across most states where Elevance Health operates. Because CarelonRx sits inside the same corporate family as the health plan itself, an audit finding does not stay contained to a claims dispute. Plan-level compliance staff and the health plan's SIU have direct visibility into the same claims data CarelonRx's audit team reviews, which shortens the distance between a routine desk audit and a fraud referral.
How CarelonRx Claims Audits Proceed
A CarelonRx review is a PBM audit like any other in its basic structure: a desk audit requesting prescription records, prior authorization documentation and proof of delivery for a sample of claims, followed by a finding letter or an on-site audit if the sample raises concerns. The PBM applies extrapolation to project the sample's error rate across the full lookback period; What a PBM Audit Really Costs: Extrapolation and Recoupment Explained walks through how that math turns a review of a few dozen claims into a six-figure recoupment demand. CarelonRx's provider manual and network agreements are not uniformly published, so pharmacies should not assume audit procedures under one plan or state apply to another; the contract in force at the time of the claim controls the review.
When an Audit Becomes a Special Investigations Unit Referral
Health plans, including Anthem-affiliated plans served by CarelonRx, generally maintain a Special Investigations Unit tasked with detecting fraud, waste and abuse in claims data. When a PBM audit surfaces a pattern the audit team considers more than a documentation gap, such as billing for quantities inconsistent with dispensing records or claims for drugs never picked up, the matter can be referred into the SIU process. SIU-track reviews typically move on a more compressed timeline, with shorter response windows and narrower documentation the pharmacy may submit to resolve the finding. A pharmacy that treats an SIU referral the same way it would a routine desk audit risks losing procedural protections that applied at the earlier stage.
A routine documentation dispute and a Special Investigations Unit referral are not the same proceeding, and the pharmacy that responds to both the same way loses ground it cannot get back.
Audit Appeal Rights Under State PBM Law
Most states have enacted a Pharmacy Audit Integrity Act or similar statute governing how a PBM, including CarelonRx, must conduct a pharmacy audit and what appeal rights the pharmacy holds. These statutes commonly require the PBM to deliver a preliminary finding, give the pharmacy a defined window, often around 30 days depending on the state, to submit documentation or file an audit appeal, and bar the PBM from collecting a recoupment until the appeal period runs or is resolved. Deadlines vary by state and can intersect with network termination proceedings when an audit finding is cited as cause; the state-by-state process CVS Caremark Audit Appeals: Deadlines and Procedural Defenses documents for one PBM does not transfer automatically to a CarelonRx matter. Pharmacies that miss a state-mandated appeal deadline forfeit rights state law otherwise guarantees.
Why Early Legal Counsel Is Critical
It is critical that pharmacies promptly retain experienced healthcare defense counsel upon receiving a CarelonRx audit notice, preliminary finding, or SIU inquiry. Early legal intervention can protect the pharmacy's rights, ensure appropriate responses to CarelonRx and the health plan's SIU, avoid inadvertent admissions, preserve state-law appeal rights, and let counsel communicate with the auditor on the pharmacy's behalf. Delaying representation can significantly affect the outcome, particularly once a routine audit escalates toward an SIU referral or a network termination proceeding.
How Health Law Alliance Can Help
Health Law Alliance defends pharmacies against CarelonRx claims audits, SIU referrals and the network termination proceedings that can follow, as part of the firm's PBM audit defense practice. The firm's approach accounts for audit appeal deadlines and documentation standards set by state PBM law, and for the added procedural stakes once a health plan's Special Investigations Unit becomes involved. If your pharmacy has received a CarelonRx audit notice or an SIU inquiry, contact us for a free, confidential consultation.
